Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) is a Healthcare company (Biotechnology) with a market capitalization of $62M. The Maz Rating grades it against the other companies in its sector.
Corbus Pharmaceuticals Holdings, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $3.01, Corbus Pharmaceuticals Holdings, Inc. trades at 0.7x book value. It runs a gross margin of 0.0%, an operating margin of 0.0% and a net margin of 0.0%. It shows return on equity of -101.0%, return on invested capital of -136.8% and a free cash flow yield of -148.2%. On the balance sheet: a debt-to-equity ratio of 0.05 and a current ratio of 3.40. Over the past 52 weeks the share price ranged from $2.81 to $12.88, with a beta of 2.79.
Corbus Pharmaceuticals Holdings, Inc. does not currently pay a dividend.
16 Wall Street analyst ratings cover the stock: 14 Buy and 2 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.